These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
413 related items for PubMed ID: 33309661
21. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing. Kumar Y, Singh H, Patel CN. J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274 [Abstract] [Full Text] [Related]
25. Potent Inhibition of SARS-CoV-2 nsp14 N7-Methyltransferase by Sulfonamide-Based Bisubstrate Analogues. Ahmed-Belkacem R, Hausdorff M, Delpal A, Sutto-Ortiz P, Colmant AMG, Touret F, Ogando NS, Snijder EJ, Canard B, Coutard B, Vasseur JJ, Decroly E, Debart F. J Med Chem; 2022 Apr 28; 65(8):6231-6249. PubMed ID: 35439007 [Abstract] [Full Text] [Related]
26. Reconstitution and functional characterization of SARS-CoV-2 proofreading complex. Ma Z, Pourfarjam Y, Kim IK. Protein Expr Purif; 2021 Sep 28; 185():105894. PubMed ID: 33933612 [Abstract] [Full Text] [Related]
36. Murine Hepatitis Virus nsp14 Exoribonuclease Activity Is Required for Resistance to Innate Immunity. Case JB, Li Y, Elliott R, Lu X, Graepel KW, Sexton NR, Smith EC, Weiss SR, Denison MR. J Virol; 2018 Jan 01; 92(1):. PubMed ID: 29046453 [Abstract] [Full Text] [Related]
38. Activity of nsp14 Exonuclease from SARS-CoV-2 towards RNAs with Modified 3'-Termini. Yuyukina SK, Barmatov AE, Bizyaev SN, Stetsenko DA, Sergeeva OV, Zatsepin TS, Zharkov DO. Dokl Biochem Biophys; 2023 Apr 01; 509(1):65-69. PubMed ID: 37340295 [Abstract] [Full Text] [Related]
39. Network analysis and molecular mapping for SARS-CoV-2 to reveal drug targets and repurposing of clinically developed drugs. More SA, Patil AS, Sakle NS, Mokale SN. Virology; 2021 Mar 01; 555():10-18. PubMed ID: 33421743 [Abstract] [Full Text] [Related]